afuresertib,
Afuresertib,
1047644-62-1,
GSK2110183C,
Afuresertib (GSK2110183),
UNII-8739X25QI3,
GSK 2110183C,
8739X25QI3,
2-Thiophenecarboxamide, N-[(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-;2-Thiophenecarboxamide, N-[(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-,
1047645-82-8,
Afuresertib [USAN:INN],
Afuresertib (USAN),
afuresertib-gsk2110183,
SCHEMBL187686,
GTPL7890,
Afuresrtib (GSK2110183),
CHEMBL2219422,
DTXSID60146711,
AFJRDFWMXUECEW-LBPRGKRZSA-N,
CHEBI:131168,
AOB87168,
BCP08435,
EX-A1574,
s7521,
ZINC43197674,
AKOS030526224,
CS-3384,
DB11648,
SB16742,
GSK 2110183,
NCGC00387879-03,
HY-15727,
FT-0697009,
A16392,
D10381,
Afuresertib, GSK-2110183, GSK-2110183B,
2-Thiophenecarboxamide, N-((1S)-2-amino-1-((3-fluorophenyl)methyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-,
N-((1S)-1-(aminomethyl)-2-(3-fluorophenyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)thiophene-2-carboxamide,
N-[(2S)-1-amino-3-(3-fluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)thiophene-2-carboxamide,
N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide,
Afuresertib [USAN],
GSK2110183,
GSK-2110183,
B4811,